Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2005
09/21/2005CN1671696A 激酶抑制剂 Kinase inhibitors
09/21/2005CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors
09/21/2005CN1671668A 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
09/21/2005CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
09/21/2005CN1671662A Piperidine derivative, process for producing the same, and use
09/21/2005CN1671650A Crystalline beta2 adrenergic receptor agonist
09/21/2005CN1671639A Novel biphenyl and biphenyl-like cannabinoids
09/21/2005CN1671424A Decoy composition for treating and preventing inflammatory disease
09/21/2005CN1671398A Compositions and methods for treating epithelia and retinal tissue diseases
09/21/2005CN1671391A Novel methods and compositions for alleviating pain
09/21/2005CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders
09/21/2005CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics
09/21/2005CN1671378A Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
09/21/2005CN1670009A Propynyl or dienyl biaromatic compounds
09/21/2005CN1669571A Chinese traditional medicine for treating enteritis and appendicitis, and method for preparing same
09/21/2005CN1669566A Preparation method of Astragaloside material medicine, the material medicine and preparation
09/21/2005CN1669555A Ointment with inflammation diminishing and pain reducing function for treating arthrophlogosis using copper complex compound and preparation method thereof
09/21/2005CN1219790C C60 glucocorticoid and it use
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219774C Non-sterioid inflammation-resisting compound
09/21/2005CN1219763C Substituted indole mannich bases
09/21/2005CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
09/21/2005CN1219545C Polygonum capitatum extract and medicinal composition preparation thereof
09/21/2005CN1219535C Swelling eliminating and pain relieving plaster
09/21/2005CN1219509C Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process
09/20/2005US6946558 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
09/20/2005US6946489 Substituted biphenyl derivatives
09/20/2005US6946478 Compounds
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946466 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
09/20/2005US6946459 Crystalline forms of 1s-[1alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl) carbonyl]amino]octahydro-6h-piridazino[1,2-a][1,2]diazepin-1-carboxamide
09/20/2005US6946264 DNA codes for polypeptides having amino acid sequences used as metalloenzyme inhibitors, for prophylaxis of autoimmune diseases or as wound healing agents
09/20/2005US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
09/20/2005US6946131 Comprises heparan sulfate proteoglyeans; antiproliferative agents
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/20/2005US6946121 Composition in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
09/20/2005US6945247 Method of treating cardio pulmonary diseases with no group compounds
09/20/2005CA2348869C Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085264A1 Sulfated oligosaccharide derivatives
09/15/2005WO2005085255A1 The extract of bulbophgllum radiatum lindl and the preparation and the use
09/15/2005WO2005085223A1 Composition for prevention and/or treatment of bone disease, functional food or health food containing the composition, and medicinal preparation containing the composition as active ingredient
09/15/2005WO2005085214A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005WO2005085212A1 Substituted pyrimidine derivative
09/15/2005WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient
09/15/2005WO2005085209A1 Basic amine compound and use thereof
09/15/2005WO2005084689A1 Radix astragli extract and production method and use thereof
09/15/2005WO2005084679A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
09/15/2005WO2005084678A1 Alkaloid formulations
09/15/2005WO2005084665A1 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof
09/15/2005WO2005084663A1 Hetero-substituted acetanilide derivates as analgesic agents
09/15/2005WO2005084662A1 The euphorbia lunulate bge extractant and production method and use thereof
09/15/2005WO2005084657A1 Compositions and methods for preventing or treating an inflammatory response
09/15/2005WO2005067502A3 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
09/15/2005WO2005009389A3 Anaplastic lymphoma kinase modulators and methods of use
09/15/2005WO2005003347A3 Dna-based aptamers for human cathepsin g
09/15/2005WO2003000844A3 Protein modification and maintenance molecules
09/15/2005US20050203300 6-Alkoxy-pyrido-pyrimidines
09/15/2005US20050203295 NO donor has a nitroso group attached to a tertiary carbon; vascular relaxants, nonsteroidal anti-inflammatory drug; water soluble; potentiated by adding glutathione, use low dosage
09/15/2005US20050203172 Novel compounds
09/15/2005US20050203158 Substituted benzimidazole compounds
09/15/2005US20050203153 Drugs with carriers as prodrugs for anticancer agents
09/15/2005US20050203145 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203127 2-(Phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
09/15/2005US20050203126 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
09/15/2005US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular
09/15/2005US20050203109 Novel Compounds
09/15/2005US20050203107 Reversible inhibitors of cysteine proteases S, K, F, L and B; inhibiting Cathepsin S; analgesics; 1-[9-(4-Chlorophenyl)-2-cyano-9H-purin-6-yl]-L-prolinamide for example
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203073 Method of treating inflammatory conditions with progesterone or progesterone analogs
09/15/2005US20050203068 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
09/15/2005US20050203022 Type II TGF-beta receptor/immunoglobulin constant region fusion proteins
09/15/2005US20050203003 Contulakin-G, analogs thereof and uses therefor
09/15/2005US20050202474 Phosphodiesterases
09/15/2005US20050202032 Use of neglected target tissue antigens in modulation of immune responses
09/15/2005US20050202013 Novel Th2-specific molecules and uses thereof
09/15/2005US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
09/15/2005US20050201996 Administering a probiotic to a household pet; contact dermatitis, actinic dermatitis, dermatitis caused by microbial infection, eczema and rosacea
09/15/2005US20050201986 Cell targeting compositions and methods of using the same
09/15/2005US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists
09/15/2005CA2812132A1 Natural igm antibodies and inhibitors thereof
09/15/2005CA2558600A1 A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
09/15/2005CA2558278A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005CA2557989A1 Sulfated oligosaccharide derivatives
09/15/2005CA2557354A1 Alkaloid formulations
09/15/2005CA2557285A1 Adenosine receptor agonists
09/15/2005CA2557268A1 Indazole derivatives and pharmaceutical compositions containing them
09/15/2005CA2556386A1 Isothiourea derivatives
09/14/2005EP1574518A2 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
09/14/2005EP1573450A2 System and method for transparent early detection, warning, and intervention during a medical procedure
09/14/2005EP1573028A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572891A2 Bone anti-resorptive compounds
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572875A2 Receptors and membrane-associated proteins
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572864A2 Human serpin polypeptides
1 ... 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 ... 1272